Results from a multicenter phase IIa study of PF-06700841 in patients with plaque psoriasis May 18, 2020
Amgen reports topline data from phase III study of Otezla for mild to moderate plaque psoriasis May 7, 2020
Phase II trial of nomacopan in bullous pemphigoid meets primary and key secondary efficacy endpoints May 4, 2020
RSS